Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring biomarkers of Alzheimer's disease based on multi-omics and Mendelian randomisation analysis.

Annals of human biology - 1 Feb 2024

Tu Kun, Zhou Wenhui, Kong Shubing

Abstract excerpt

BACKGROUND: Alzheimer's disease (AD) is an irreversible neurodegenerative disorder with no fully curative treatment. AIM: This study aims to identify effective biomarkers for AD diagnosis and treatment by combining multi-omics and Mendelian randomisation (MR) analyses. SUBJECTS AND METHODS: Positron emission tomography (PET), single nucleotide polymorphism (SNP), and gene expression data of AD patients using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Biomarkers
Share to Genome-Wide Association Study

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mendelian Randomization Analysis

Share to Multiomics

Share to Polymorphism, Single Nucleotide

Share to Positron-Emission Tomography

Share to Quantitative Trait Loci

Source

Identifiers

PMID: 39508514
DOI: 10.1080/03014460.2024.2415035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring biomarkers of Alzheimer's disease based on multi-omics and Mendelian randomisation analysis.PMID 39508514Read ↗

Identification of causally linked blood biomarkers for Alzheimer's disease via reverse transcriptome-wide Mendelian randomization.Semantic proximity Read ↗

Integrative multi-omics approaches identify molecular pathways and improve Alzheimer’s Disease risk predictionSemantic proximity Read ↗

Integrative analysis of single-nucleus RNA sequencing and Mendelian randomization to explore novel risk genes for Alzheimer's disease.Semantic proximity Read ↗

Integrative multi-omics approaches identify molecular pathways and improve Alzheimer's disease risk prediction.Semantic proximity Read ↗

Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer’s disease and three causality networks of AD: the GR@ACE projectSemantic proximity Read ↗

Predicting gene regulatory networks from multi-omics to link genetic risk variants and neuroimmunology to Alzheimer’s disease phenotypesSemantic proximity Read ↗

Systematic evaluation of multifactorial causal associations for Alzheimer's disease and an interactive platform MRAD developed based on Mendelian randomization analysis.Semantic proximity Read ↗

omicSynth: an Open Multi-omic Community Resource for Identifying Druggable Targets across Neurodegenerative DiseasesSemantic proximity Read ↗

Systematic evaluation of multifactorial causal associations for Alzheimer's disease and an interactive platform based on Mendelian randomization analysis——MRADSemantic proximity Read ↗

Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domainsSemantic proximity Read ↗

Identify Alzheimer’s disease subtypes and markers from multi-omic data of human brain and blood with a subspace merging algorithmSemantic proximity Read ↗

Identification of plasma cell subsets and molecular markers of Alzheimer's disease based on single-cell weighted gene co-expression network analysis and Mendelian randomization analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.